Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: This study aimed to assess the efficacy of innovative Chemiluminescence Immunoassay (CLIA) in testing Cryptococcal Antigen (CrAg) across two medical centers, employing the FDA-approved CrAg Lateral Flow Assay (LFA) by IMMY as a reference standard.

Methods: The study encompassed patients diagnosed with cryptococcosis at West China Hospital of Sichuan University (HX) between July 2022 and May 2023, and Suzhou Fifth People's Hospital (SZ) from September 2020 to September 2023. All specimens underwent simultaneous detection using the LFA (IMMY, Norman, USA) and CLIA (Chuanglan, Suzhou, China).

Results: A total of 628 patients were enrolled, revealing a remarkable 99.20% concordance between LFA and CLIA (623/628, 99.20%). The LFA exhibited a sensitivity of 96.83% (244/252) and specificity of 98.35% (179/182). Among the 42 patients with unaltered CrAg titers, the changes of Signal-to-Cut-Off ratio (ΔS/CO) results exhibited a noteworthy discrepancy, with 71.43% (30/42) demonstrating a decreasing trend in ΔS/CO of at least 10%.

Conclusions: The CLIA method demonstrated commendable specificity and sensitivity, exhibiting a high level of agreement with the FDA-approved LFA method. Additionally, CLIA demonstrated superior utility for treatment monitoring compared to LFA, offering continuous insight into the fluctuation of CrAg concentrations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11634829PMC
http://dx.doi.org/10.3389/fcimb.2024.1451539DOI Listing

Publication Analysis

Top Keywords

cryptococcal antigen
8
medical centers
8
lfa immy
8
lfa
6
clia
5
evaluation cryptococcal
4
antigen testing
4
testing novel
4
novel chemiluminescence
4
chemiluminescence assay
4

Similar Publications

Cryptococcosis is a fungal infection commonly found in immunocompromised individuals, but it can also affect immunocompetent individuals. A pregnant woman with myasthenia gravis, HIV-negative, died after a diagnosis of tuberculosis. An autopsy revealed a mediastinal mass and organ involvement, indicating a disseminated cryptococcal infection.

View Article and Find Full Text PDF

Introduction: Cryptococcal meningitis (CM) is the second leading cause of AIDS-related mortality where the burden of advanced HIV disease is concentrated. Advances in diagnostics and treatment, including cryptococcal antigen (CrAg) screening and short-course antifungal regimens, have improved clinical outcomes in trials, but replicating these same benefits in routine care has proven more difficult.

Areas Covered: This review outlines the biological rationale for CrAg screening and examines the major operational barriers to effective CM diagnosis in low-income countries.

View Article and Find Full Text PDF

A case of humidifier lung potentially caused by Cryptococcuslaurentii.

Respir Investig

August 2025

Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8501, Japan.

Humidifier lung is a type of hypersensitivity pneumonitis caused by repeated inhalation of contaminated humidifier vapor containing antigens. Identification of specific antigens is crucial for the management of hypersensitivity pneumonitis. We report a case of humidifier lung in a 60-year-old man who presented with fever and dyspnea.

View Article and Find Full Text PDF

Background: Despite efforts to optimize therapy for HIV-associated cryptococcal meningitis (CM), survival outcomes remain poor. It is unclear how the cerebrospinal fluid (CSF) cellular immune phenotype and activation contribute to 2-week and 1-year survival following CM.

Methods: We compared baseline CSF mononuclear cell phenotype and activation among adults with HIV-associated cryptococcal meningitis who died within 2-weeks of CM diagnosis to survivors who were alive at 1-year.

View Article and Find Full Text PDF

Cryptococcosis is a fungal infection caused by and that primarily affects the brain and lungs. While typically infects immunodeficient hosts, it can also infect immunocompetent hosts, particularly in tropical and subtropical regions. Recently, there has been a rise in reported cases globally.

View Article and Find Full Text PDF